Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Express Scripts
AstraZeneca
Harvard Business School
Boehringer Ingelheim

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

SIMULECT Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Tradename: SIMULECT
Patents:116
Applicants:1
BLAs:1
Suppliers: see list1
Recent Clinical Trials: See clinical trials for SIMULECT
Recent Clinical Trials for SIMULECT

Identify potential brand extensions & biosimilar entrants

SponsorPhase
The 923th Hospital of People's Liberation ArmyPhase 4
Fourth Affiliated Hospital of Guangxi Medical UniversityPhase 4
First Affiliated Hospital of Guangxi Medical UniversityPhase 4

See all SIMULECT clinical trials

Patent Text Search: US Patents for SIMULECT

These patents were identified by searching patent claims

Supplementary Protection Certificates for SIMULECT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
91902 Luxembourg   Start Trial 91902, EXPIRES: 20260523
CA 2015 00043 Denmark   Start Trial PRODUCT NAME: TRASTUZUMAB OG REKOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: C(20135603) /EU/1/00/145/002 20130826
CR 2016 00031 Denmark   Start Trial PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; NAT. REG. NO/DATE: EU/1/98/067/003-004 20140326; FIRST REG. NO/DATE: EU EU/1/98/067 20140326
PA2011014 Lithuania   Start Trial PRODUCT NAME: BELATACEPTUM; REGISTRATION NO/DATE: EU/1/11/694/001, 2011 06 17 EU/1/11/694/002 20110617
122011100063 Germany   Start Trial PRODUCT NAME: BELATACEPT; REGISTRATION NO/DATE: EU/1/11/694/001-002 20110617
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Mallinckrodt
AstraZeneca
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.